Please use this identifier to cite or link to this item:
|Title:||Genetic testing in epilepsy: what should you be doing?||Austin Authors:||Scheffer, Ingrid E||Affiliation:||Professor of Paediatric Neurology, Departments of Medicine and Paediatrics, The University of Melbourne, Austin and Royal Children's Hospital, Senior Principal Research Fellow, Florey Neuroscience Institutes, and Director of Paediatrics, Austin Health, Melbourne, Australia||Issue Date:||1-Jul-2011||Publication information:||Epilepsy Currents / American Epilepsy Society; 11(4): 107-11||Abstract:||With the burgeoning array of molecular tests available in the epilepsies, the clinician needs to know which tests to order for each patient. Epileptic encephalopathies are the most important clinical group for genetic testing with an increasing number of distinctive epilepsy syndromes being recognized. Identification of the causative mutation affects treatment as well as prognostic and genetic counseling.||Gov't Doc #:||21836823||URI:||http://ahro.austin.org.au/austinjspui/handle/1/11318||DOI:||10.5698/1535-7511-11.4.107||URL:||https://pubmed.ncbi.nlm.nih.gov/21836823||Type:||Journal Article|
|Appears in Collections:||Journal articles|
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.